2 hours Benitec Biopharma (NASDAQ:BNTC) Now Covered by OppenheimerMarketBeat
Oppenheimer assumed coverage on shares of Benitec Biopharma in a research report on Wednesday. They issued an “outperform” rating and a $35.00 price target for the company.
X